CardiNor signs US distribution agreement with IBL-America for the CardiNor Research Use Only Secretoneurin ELISA test
Jul 19th 2022
Oslo, Norway, July 19th, 2022: Cardiovascular DX
company CardiNor AS today announces that it has signed an exclusive agreement
with IBL-America for sales of the CardiNor Secretoneurin ELISA test in
… read more